Articles

PP06 Hereditary predisposition syndromes to malignant hemopathies (HPSMH)

BJH - 2018, issue Abstract Book BHS, february 2018

S. Dupriez , A. Ferrant , M-C. Vekemans MD, B. Brichard , L. Michaux MD, PhD, T. Connerotte , E. Van den Neste MD, PhD, C. Vermylen , L. Knoops MD, PhD, C. Graux MD, PhD, F. Duhoux , C. Lambert MD, X. Poiré MD, H.A. Poirel MD, PhD

Read more

P79 Atypical bone pain after allogeneic bone marrow transplantation for myelofibrosis

BJH - volume 8, issue Abstract Book BHS, february 2017

G. Verstraete , S. Lefevre , S. Bailly MD, G. Di Prinzio , J. Devreux , J-P. Defour PhD, P. D’Abadie , P. Van Eeckhout , F. Kino , C. Goemare , N. Lepage , L. Michaux MD, PhD, V. Havelange MD, PhD, E. Van den Neste MD, PhD, C. Lambert MD, L. Knoops MD, PhD, M-C. Vekemans MD, X. Poiré MD

Read more

Discontinuation of imatinib in Belgian patients with chronic myeloid leukaemia

BJH - volume 7, issue 5, october 2016

P. Mineur MD, C. Doyen MD, PhD, N. Straetmans MD, PhD, K. Van Eygen MD, D. Pranger MD, A. Bosly MD, PhD, M. André MD, T. Devos MD, PhD, L. Knoops MD, PhD, On behalf of the MPN Belgian Hematological Society subcommittee

Summary

This article describes the Belgian register of chronic myeloid leukaemia patients who have stopped their treatment with imatinib in conditions comparable to the French STIM trial results: 44% remained in major molecular response off therapy; relapses appear rapidly after stopping imatinib and are responsive when the treatment is resumed.

(BELG J HEMATOL 2016;7(5):184–6)

Read more

PP4.2 The clinical relevance of imatinib (Im) plasma trough concentration in patients with chronic myelocytic leukemia (CML) in chronic phase. A Belgian retrospective study

BJH - volume 7, issue Abstract Book BHS, january 2016

F. Van Obbergh MD, L. Knoops MD, PhD, Y. Beguin MD, PhD, C. Graux MD, PhD, S. Benghiat MD, PhD, K. Kargar-Samani , D. Bauwens , A. Efira MD, C. Dubois , C. Springael MD, PhD, L. Montfort , T. Connerotte , A. Delannoy , P. Wallemacq

Read more

PP4.4 A retrospective study of 109 patients with essential thrombocythemia with a focus on the delay in the diagnosis

BJH - volume 7, issue Abstract Book BHS, january 2016

F. Lurquin , V. Lannoy , J-P. Defour PhD, L. Knoops MD, PhD

Read more

P4.10 The Ponatinib Named Patient Programme (NPP): Real-life Data from Belgian Patients

BJH - volume 7, issue Abstract Book BHS, january 2016

L. Knoops MD, PhD, G. Verhoef MD, PhD, Z. Berneman MD, PhD, D. Selleslag MD, N. Straetmans MD, PhD, L. Noens MD, PhD, P. Lewalle MD, PhD, M. André MD, D. Pranger MD, P. Zachée MD, PhD, E. Strobbe , L.J. McGarry , T. Devos MD, PhD

Read more

P4.11 Unusual cutaneous paraneoplastic syndrome in the setting of acute myeloid leukemia

BJH - volume 7, issue Abstract Book BHS, january 2016

T. Tamakloe , N. Meité , S. Amat , P. Janssens , L. Marot , J-P. Defour PhD, P. Saussoy MD, PhD, H. Poirel , L. Michaux MD, PhD, E. Van den Neste MD, PhD, L. Knoops MD, PhD, V. Havelange MD, PhD, C. Lambert MD, X. Poiré MD, M-C. Vekemans MD

Read more